Piur Imaging, a medical device company that specializes in AI-driven tomographic 3D ultrasound, has raised €5.6 million (US$6 million) in a growth capital funding round.

The investment was led by Aescuvest Capital Partners, a healthcare-focused investment firm based in Frankfurt, Germany.

Headquartered in Vienna, the company develops technology that converts standard 2D ultrasound systems into 3D imaging platforms.

Its products, including the Piur tUS Infinity and the PIUR tUS inside, are designed to improve diagnostic accuracy by capturing entire organs in a single scan.

Both products have received FDA clearance and CE marking.

The funding will support Piur Imaging’s expansion in the United States, following the establishment of its US subsidiary.

The company also intends to forge partnerships with ultrasound manufacturers and develop additional clinical applications.

🔗 Source: Piur Imaging

🧠 Food for thought

1️⃣ Ultrasound’s evolution from 2D to 3D addresses a decades-old limitation

PIUR’s technology addresses one of ultrasound’s most persistent historical challenges: operator variability in image acquisition and interpretation.

Since ultrasound’s medical adoption in the 1940s, the technology has progressed through distinct evolutionary phases, from static A-mode and B-mode imaging to real-time scanning in the late 1970s and color Doppler capabilities in the 1980s 1.

Despite these advances, the fundamental limitation of user-dependency has remained, with diagnostic conclusions traditionally drawn from operator-selected 2D slices rather than comprehensive volumetric data.

The shift toward 3D imaging represents the latest phase in ultrasound’s technical evolution, following a pattern of innovation that has consistently aimed to reduce subjectivity and improve reproducibility in clinical settings.

This progression mirrors earlier transformative moments in ultrasound history, such as the transition from static to real-time imaging at institutions like Ochsner Health System in 1979, which expanded diagnostic capabilities 1.

2️⃣ Add-on innovation strategy navigates regulatory and adoption barriers